GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » EBITDA Margin %

Corix Bioscience (Corix Bioscience) EBITDA Margin % : 0.00% (As of Sep. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Corix Bioscience's EBITDA for the three months ended in Sep. 2017 was $-0.28 Mil. Corix Bioscience's Revenue for the three months ended in Sep. 2017 was $0.00 Mil. Therefore, Corix Bioscience's EBITDA margin for the quarter that ended in Sep. 2017 was 0.00%.


Corix Bioscience EBITDA Margin % Historical Data

The historical data trend for Corix Bioscience's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience EBITDA Margin % Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
EBITDA Margin %
Get a 7-Day Free Trial - - - - -560.23

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Corix Bioscience's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corix Bioscience's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's EBITDA Margin % falls into.



Corix Bioscience EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Corix Bioscience's EBITDA Margin % for the fiscal year that ended in Dec. 2016 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=-3.888/0.694
=-560.23 %

Corix Bioscience's EBITDA Margin % for the quarter that ended in Sep. 2017 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2017 )/Revenue (Q: Sep. 2017 )
=-0.279/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Corix Bioscience  (GREY:CXBS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Corix Bioscience EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Corix Bioscience (Corix Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines